Holen Sie sich die Stockscreener-App
1.125
1.35%
0.015
Veraxa Biotech Ag Aktie (VRXA) Neueste Nachrichten
VERAXA Biotech Provides Overview on Implementation of FDA-Aligned Human-Relevant Models into R&D Strategy - GlobeNewswire Inc.
Veraxa Biotech AG (VRXA) Stock Price & News - Syfe
Form 4 Veraxa Biotech AG For: 29 September By Investing.com - Investing.com Nigeria
Form 4 Veraxa Biotech AG For: 29 September By Investing.com - Investing.com UK
LAWR Stock Price, Quote & News - Syfe
DSWL Stock Price, Quote & News - Syfe
Veraxa Biotech (VRXA) CFO named insider with no reported shares - Stock Titan
Veraxa Biotech AG Stock Price: VRXA Stock Chart, Market Cap & News Today - CoinGecko
VERAXA Biotech Appoints Dr. Christoph Erkel as CSO to Steer BiTAC® Toward Clinical Trials - citybuzz -
VERAXA Biotech Designates Raju Willener as CFO - Yahoo Finance
VERAXA Biotech (NASDAQ: VRXA) Appoints Raju Willener As Chief Financial Officer - Menafn
Veraxa Biotech AG (NASDAQ: VRXA) Revises Prospectus for Up to 120.3 Million Shares and Warrants - Kalkine Media
Veraxa Biotech AG (NASDAQ: VRXA) Names Raju Willener as CFO Following De-SPAC Completion - Kalkine Media
VERAXA Biotech (VRXA) Appoints Raju Willener as Chief Financial Officer - Yahoo Finance
Veraxa Biotech (VRXA) Insider Trading Activity 2026 - marketbeat.com
VERAXA Biotech (NASDAQ: VRXA) Appoints Raju Willener as Chief Financial Officer - TradingView
VRXA Rises As Veraxa Biotech AG Draws Trader Focus - timothysykes.com
Veraxa Biotech AG Company Profile & Introduction - Moomoo
VRXA Jumps As Traders Focus On Biotech Breakout Setup - timothysykes.com
VERAXA Biotech Appoints Veteran Finance Executive Raju Willener as CFO to Drive Capital Strategy and Oncology Pipeline Growth - citybuzz -
Veraxa Biotech AG (VRXA) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Veraxa Biotech names Raju Willener as chief financial officer By Investing.com - Investing.com Australia
Veraxa Biotech AG Announces Chief Financial Officer Changes - marketscreener.com
Veraxa Biotech stock rises after naming Raju Willener as CFO By Investing.com - Investing.com India
Veraxa Biotech stock rises after naming Raju Willener as CFO By Investing.com - Investing.com South Africa
Veraxa Biotech stock rises after naming Raju Willener as CFO By Investing.com - Investing.com Australia
Veraxa Biotech stock rises after naming Raju Willener as CFO By Investing.com - Investing.com Canada
Veraxa Biotech stock rises after naming Raju Willener as CFO By Investing.com - Investing.com Nigeria
Veraxa Biotech stock rises after naming Raju Willener as CFO - investing.com
Veraxa Biotech names Raju Willener as chief financial officer By Investing.com - Investing.com South Africa
Finance veteran behind CHF 30B portfolios joins Veraxa Biotech (VRXA) as CFO - Stock Titan
Veraxa Biotech names Raju Willener as chief financial officer By Investing.com - Investing.com Canada
Veraxa Biotech names Raju Willener as chief financial officer By Investing.com - Investing.com Nigeria
Veraxa Biotech names Raju Willener as chief financial officer - Investing.com
Veraxa Biotech names Raju Willener as chief financial officer By Investing.com - Investing.com India
VERAXA Biotech Appoints Raju Willener as Chief Financial Officer - kommunikasjon.ntb.no
Insider Buys Additional CHF75k In Veraxa Biotech Stock - simplywall.st
Veraxa Biotech AG Company Profile & Introduction - Moomoo
Veraxa Biotech (VRXA) 10K Form and Latest SEC Filings 2026 - MarketBeat
Veraxa Biotech (VRXA) Stock Price, News & Analysis - marketbeat.com
Veraxa Biotech (VRXA) Stock Chart and Price History 2026 - marketbeat.com
Veraxa Biotech (VRXA) director adds 50K shares in open-market buy - Stock Titan
Veraxa Biotech (VRXA) CEO now holds 5,000 ordinary shares - Stock Titan
VERAXA Biotech (NASDAQ: VRXA), Secarna Partnership Milestone Opens New Potential Market for Conjugation T - Benzinga
Early lab data advance Veraxa (Nasdaq: VRXA) autoimmune AOC - stocktitan.net
Veraxa and Secarna report positive early results from AOC study By Investing.com - Investing.com India
Veraxa Biotech AG - Via Ritzau
VERAXA Biotech and Secarna Pharmaceuticals Achieve Research Milestone in Antibody Oligonucleotide Conjugate (AOC) Alliance - The Manila Times
VERAXA Biotech AG: Valuation Ratios, Analysts' Forecasts - marketscreener.com
Veraxa Biotech (VRXA) interim CFO discloses zero share ownership - Stock Titan
1.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):